InvestorsHub Logo
Followers 1
Posts 144
Boards Moderated 0
Alias Born 01/24/2020

Re: labner post# 259977

Wednesday, 04/01/2020 9:28:42 PM

Wednesday, April 01, 2020 9:28:42 PM

Post# of 425915
Just amazing to hear what was said on this call. Many people say JT has lost all leverage and that’s probably true. But let’s play this out for a second.

1) April: File the appeal, then the injunction and hope like hell the injunction is granted.

2) May/June: Flood the airwaves with DTC and sell the hell out of V.

3) 4th Quarter: EMA approval. Is it too much to hope for even broader label?

4) Jan/Feb: Now it’s crunch time as Fed Circuit gears up to hear oral arguments for the appeal. Per the attorney on the Jefferies call, Amarin has a legitimate shot at this.

5) JT already has deal cut with PFE, GILD, JNJ, NVS, NVO or GSK, etc...with valuation pegged to Fed Circuit decision. If DU verdict upheld we get the EU/ROW price of $15-35 per share. If DU verdict overturned we get $50-75 per share.

So on a flip of the coin we end up with anywhere from $15-75 per share in less than a year and right now we sit at $5. Where am I going wrong?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News